Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A silver lining of neuroinflammation: Beneficial effects on myelination.
Microglia across the lifespan: from origin to function in brain development, plasticity and cognition.
Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
Avonex drug warning letter, severe hypatic injury
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses.
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
Specific inhibition of secreted NRG1 types I-II by heparin enhances Schwann Cell myelination.
Optical Coherence Tomography in Multiple Sclerosis.
Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases.
Differences in the burden of psychiatric comorbidity in MS vs the general population.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
CombiRx for MS not better than monotherapy
Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study.
Individual Neuronal Subtypes Exhibit Diversity in CNS Myelination Mediated by Synaptic Vesicle Release.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.
Sema4A inhibits the therapeutic effect of IFN-β in EAE.
Eosinophilic Fasciitis-like Disorder Developing in the Setting of Multiple Sclerosis Therapy.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.

Pages